AS
Ascentage Pharma Group International
ASPHF · OTC
$4.53 +0.00% (+$0.00)
Market Cap ¥11.3B
P/E Ratio -
Div. Yield -
ROE 172.24%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 8.55x
P/S 20.27x
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 48.01%
Rev. growth 38.68%
FCF growth N/A
Profitability
20 /100
Weak Net margin 216.47%
Op. margin 211.14%
FCF margin 214.86%
Quality
2 /100
Poor ROE 172.24%
ROA 30.53%
Asset turnover 0.14x
Debt
37 /100
Moderate Current ratio 1.79x
Int. coverage -22.42x
Debt/Equity 1.49x
Stability
26 /100
Unstable Rev. volatility 209.46%
EPS volatility 107.94%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ASPHF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dajun Yang
Employees
767
Headquarters
Suzhou
Prihajajoči dogodki
31 MAR.
Earnings
Upcoming earnings report